Carr Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Carr Financial Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379K	Sell	756 -9	-1%	-$4.32K	0.09%	129
2026 Q1	$376K	Buy	765 +9	+1%	+$4.88K	0.1%	119
2025 Q4	$438K	Buy	756 +4	+0.5%	+$2.26K	0.12%	113
2025 Q3	$365K	Buy	752 +1	+0.1%	+$465	0.1%	128
2025 Q2	$305K	Hold	751	–	–	0.09%	142
2025 Q1	$374K	Buy	751 +1	+0.1%	+$542	0.12%	116
2024 Q4	$390K	Sell	750 -450	-38%	-$247K	0.12%	124
2024 Q3	$742K	Buy	1,200 +1	+0.1%	+$592	0.22%	79
2024 Q2	$663K	Hold	1,199	–	–	0.21%	83
2024 Q1	$697K	Hold	1,199	–	–	0.23%	72
2023 Q4	$636K	Hold	1,199	–	–	0.24%	71
2023 Q3	$545K	Hold	1,199	–	–	0.22%	81
2023 Q2	$626K	Buy	1,199 +68	+6%	+$36.7K	0.25%	71
2023 Q1	$652K	Hold	1,131	–	–	0.29%	70
2022 Q4	$623K	Buy	+1,131	New	+$599K	0.33%	69

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Carr Financial Group's TMO Position: Q2 2026 in Review

Carr Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, selling an estimated $4.32K and leaving 756 shares worth $379K. The position accounts for 0.09% of the portfolio, ranked #129.

Carr Financial Group first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $742K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Carr Financial Group held 756 shares of Thermo Fisher Scientific worth $379K as of Q2 2026.
Carr Financial Group sold 9 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.32K.
Thermo Fisher Scientific made up 0.09% of Carr Financial Group's portfolio in Q2 2026, its #129 holding.
Carr Financial Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
Carr Financial Group's Thermo Fisher Scientific position peaked at $742K in Q3 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Carr Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.